Latest Breaking News On - One life science - Page 3 : comparemela.com

VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies Share Article Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced hepatocellular carcinoma (HCC). The renewed agreement is a testament to the experience and capabilities of the VGXI team in meeting the challenging requirements of this project. THE WOODLANDS, Texas (PRWEB) March 16, 2021 VGXI, Inc., an industry leading manufacturer for pre-clinical through cGMP clinical plasmid DNA, announced that its partner Geneos Therapeutics, Inc. has executed a new purchasing contract under their current Clinical Manufacturing Supply Agreement to support the expansion of the ongoing GT-30 clinical trial. The Geneos trial is focused on treatment of patients with advanced hepatocellular carcin

Young parkWestern australiaSoult ukpyolsiSouth koreaUnited statesNiranjany sardesaiGeneone life science incVgxi incGeneos expand partnership for personalized therapyGeneos therapeutics incExpand partnershipGeneos therapeuticsClinical manufacturing supply agreementChief executive officerOne life scienceSecurities litigation reform act